The activated NF-kB pathway in MSCs from Systemic lupus erythematosus (SLE) patients inhibits osteoblastic differentiation through BMP/Smad signaling pathway, which may participate in the pathology of osteoporosis in SLE patients9. Here, NFKB1 is linked to systemic lupus erythematosus.